Key result
Propafenone administration in patients with symptomatic ventricular arrhythmias did not demonstrate clinically significant beta-blocking effects on heart rate or blood pressure at rest or during exercise.
Why the study?
Does propafenone exert clinically significant beta-blocking effects on electrocardiographic variables in patients with symptomatic ventricular arrhythmias?
Observational (n=42)
Does propafenone exert clinically significant beta-blocking effects on electrocardiographic variables in patients with symptomatic ventricular arrhythmias?
Propafenone demonstrates expected class 1c antiarrhythmic effects but lacks clinically significant beta-blocking effects at rest or during exercise.
Answers are grounded in this paper and cite their sources.
Propafenone lacks clinically significant beta-blocking effects in symptomatic VA; supports class Ic profile but leaves ECG impact open for RCTs.
To study possible beta-blocking effects of propafenone, a class 1c antiarrhythmic agent, electrocardiographic variables were studied at rest and during exercise. Forty-two patients with symptomatic ventricular arrhythmias were included. In 31 patients, exercise electrocardiograms before and after propafenone were available for study. The mean dose of propafenone was 603 mg for all 42 patients, 585 mg for patients undergoing exercise testing (range 450-1200). At rest, the PR interval, duration of P wave and QRS complex changed significantly without any change in the resting heart rate and QTc interval. During exercise there were no changes after propafenone in peak heart rate, PR interval, QTc interval, duration of exercise, or blood pressure. We conclude that, while class I effects are evident both at rest and after exercise, no clinically significant beta-blocking effects of propafenone could be demonstrated either at rest or during exercise.
No takes yet. Share an insight, caveat, or question.
Cheriex et al. (1987) conducted an observational in Symptomatic ventricular arrhythmias (n=42). Propafenone vs. Baseline (before propafenone) was evaluated on Electrocardiographic variables at rest and during exercise. Propafenone administration in patients with symptomatic ventricular arrhythmias did not demonstrate clinically significant beta-blocking effects on heart rate or blood pressure at rest or during exercise.
Synapse has enriched 10 related papers. Consider them for comparative context: